Native Human IgG Protein
Beta LifeScience
SKU/CAT #: BLA-11784P
Native Human IgG Protein
Beta LifeScience
SKU/CAT #: BLA-11784P
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Accession | P01857 |
Synonym | FLJ39988 FLJ40036 FLJ40253 FLJ40587 FLJ40789 FLJ40834 G1m marker G2m marker G3m marker G4m marker HDC Heavy chain disease protein Human immunglobulin G Ig gamma 1 chain C region Ig gamma 2 chain C region Ig gamma 3 chain C region Ig gamma 4 chain C region IgG heavy chain locus IGHG 1 IGHG 2 IGHG 3 IGHG 4 IGHG1 IGHG2 IGHG3 IGHG4 Immunoglobulin Gm1 Immunoglobulin Gm3 Immunoglobulin Gm4 Immunoglobulin heavy constant gamma 1 immunoglobulin heavy constant gamma 1 (G1m marker) Immunoglobulin heavy constant gamma 2 immunoglobulin heavy constant gamma 2 (G2m marker) Immunoglobulin heavy constant gamma 3 immunoglobulin heavy constant gamma 3 (G3m marker) Immunoglobulin heavy constant gamma 4 immunoglobulin heavy constant gamma 4 (G4m marker) MGC117419 MGC45809 |
Description | Native Human IgG Protein is native.. It is a Full length protein |
Source | Native |
Purity | 96% .IgA and IgM levels are <1% of the total IgG content by RID. |
Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method |
Formulation | Lyophilised |
Stability | The recombinant protein samples are stable for up to 12 months at -80°C |
Reconstitution | See related COA |
Unit Definition | For Research Use Only |
Storage Buffer | Shipped at 4°C. Store at 4°C prior to reconstitution. Store at -80°C. |
Target Details
Target Function | Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen. |
Subcellular Location | Secreted. Cell membrane. |
Database References | |
Associated Diseases | Multiple myeloma (MM) |